CCI Clinical Trials Team Serves Cancer Patients Near, Far - Clearview Cancer Institute

(May 20, 2022)-The team at Clearview Cancer Institute has been involved in cancer research for more than three decades.  We have a department dedicated to research and clinical trials.  Our commitment remains with new targeted therapies, better detection methods, genomic testing and personalized medicine. 

 

 

Pictured: Lisa Chapuran, Mary Hughes, Mariam Parizad, Leslie Smoot

  

Did you know:

  • The CCI research team has participated in the FDA approval of the following medications: Herceptin, Avastin, Rituxan and more.
  • The CCI research team has a combined 30 years experience in research including 4 RNs that serve as study coordinators, a regulatory/investigational product coordinator, and a lab and registry coordinator.
  • Clinical trials have improved childhood cancer survival from less than 10% to 80% survival.
  • Clinical trials can allow access to therapies that are up and coming and not available otherwise.
  • Developing new medicine takes at least 10 years on average to receive FDA approval.
  • Clinical trials look at new ways to prevent, detect, or treat disease.
  • Groundbreaking scientific advances in the present and the past were possible only because of participation of volunteers, both healthy and those diagnosed with an illness, in clinical research.

 

 

A special thanks to these physicians who serve as primary investigators:

Dr. Paul Dang

Dr. Jorge Diaz

Dr. Kanth Katragadda

Dr. Brian Mathews

Dr. Daniel Schreeder

Dr. Marshall Schreeder